Given that the frequency of homozygous MTAP deletions in GBM is around 50%, we would have expected to observe a higher MTA level in the cerebrospinal fluid from at least some GBM compared to the normal brain (Supplementary Fig. 11a, b). The gene discussed is MTAP; the disease is glioblastoma.